In a study based on mice models of colitis and colitis-associated cancer (CAC), necrostatin-1 significantly suppressed colitis symptoms in mice, including weight loss, colon shortening, colonic mucosa damage and its severity, and the excessive production of interleukin-6. The gene discussed is IL6; the disease is colitis.